Ipratropium bromide and Minoxidil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Minoxidil (minoxidil). Common drug interactions include arthritis among females and blood alkaline phosphatase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Minoxidil. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Minoxidil?

Minoxidil has active ingredients of minoxidil. It is often used in hair loss. eHealthMe is studying from 29,925 Minoxidil users. Check the latest studies of Minoxidil.

On Jul, 18, 2026

17 people who take Ipratropium bromide and Minoxidil together, and have interactions are studied.

Ipratropium bromide and Minoxidil drug interactions.

What are the common drug interactions of Ipratropium Bromide and Minoxidil, by gender? *:

female:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthenia (weakness)
Blood pressure decreased
Chills (felling of cold)
Headache (pain in head)
Heart rate increased
Infusion related reaction
Infusion site pain
Infusion site scar
Pain

male:

Blood alkaline phosphatase increased
Chronic kidney disease
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Emotional distress
Fall
Femur fracture
Haemorrhage (bleeding)
Hyperhidrosis (abnormally increased sweating)
Loss of consciousness

What are the common drug interactions of Ipratropium Bromide and Minoxidil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blood alkaline phosphatase increased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
Hyperhidrosis (abnormally increased sweating)
Loss of consciousness
Nausea (feeling of having an urge to vomit)
Type 2 diabetes mellitus

50-59:

n/a

60+:

Blood pressure decreased
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Trigger finger
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)
Psychomotor hyperactivity (feelings of extreme restlessness)
Dyspnoea (difficult or laboured respiration)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 5 people, 29.41%
Pneumonia: 3 people, 17.65%
Constipation: 2 people, 11.76%
Sleep Disorder: 2 people, 11.76%
High Blood Pressure: 2 people, 11.76%
Asthma: 2 people, 11.76%
High Blood Cholesterol: 2 people, 11.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
Diarrhea: 1 person, 5.88%
Heart Rate Irregular: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Minoxidil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously